Fluoxetme has also been shown to have some efficacy in the treatment of obsessive-compulsive disorders, bulimia nervosa, and obesity (1-4). Both fluoxetine and its hepatic metabolite, norfluoxetine, are specific inhibitors of serotonin reuptake in the central nervous system, enhancing serotonin neurotransmission without the cholinergic and cardiovascular side effects found with the tricycic antidepressants
Indexing Terms: antidepressants/variation, source of/drug monitoring/chromatography, reversed-phase Prozac#{174} (fluoxetine) is the first widely marketed member of the second-generation serotonin-selective antidepressants.
Fluoxetme has also been shown to have some efficacy in the treatment of obsessive-compulsive disorders, bulimia nervosa, and obesity (1) (2) (3) (4) . Both fluoxetine and its hepatic metabolite, norfluoxetine, are specific inhibitors of serotonin reuptake in the central nervous system, enhancing serotonin neurotransmission without the cholinergic and cardiovascular side effects found with the tricycic antidepressants (1, 5, 6). Although safer to prescribe than tricycics, the long half-lives of fluoxetine (2-3 days) and norfiuoxetine (7-15 days) can result in potentially seriousdrug interactions because substantial concentrations may circulate in serum weeks after discontinuation of therapy (2, 3, 6, 7). Fluoxetine can increase the pharmacologic effects of coadministered tricycics, increase the serum concentrations of lithium, prolong the half-life of diazepam, and pose serious complications in combination with monoamine oxidase inhibitors (3). At least four deaths have resulted from 38 overdoses with either fluoxetine alone (ingestion of >6 g) Here we describe the development of an automated HPbO method with automated extraction for the assay of fluoxetine and norfiuoxetine in serum.
Materials and Methods

Reagents
Fluoxetine 
Results
Assay Characteristics
Chromatographic resolution of fluoxetine and norfluoxetine takes <8 miii (Fig. 1) . Norfluoxetine elutes before fluoxetine, with retention times (relative to protriptyline) of 1.36 and 1.63, respectively.
The limit of detection was 10 pg/b for both analytes. Linearity was judged by evaluation of calibrator concentrations of 20-1000 pg/b (Fig. 2) . trations remained stable in a serum matrix for at least 48 h at room temperature, 1 week at 4#{176}C, and several months at -20#{176}C.
Intraassay precision was determined by successive analysis of calibrators in a single run. The CVs tended to be lower at the calibration set point: at concentrations of 200, 500, and 50 u.gfL, CVs were respectively2.0%, 5.1%, and 5.6% for fluoxetine, and 2.5%, 5.1%, and 3.8% for norfluoxetine (n = 11-15). Interassay imprecision was evaluated by the analysis of the three calibrators in multiple daily runs. hnterassay CVs were 4-7% for both analytes; specifically, at the same concentrations just mentioned, they were respectively 3.9%, 5.8%, and 6.5% for fluoxetine, and 3.9%, 4.9%, and 6.9% for norfluoxetine (n = 33).
Interferences
An extensive interference study was conducted by adding to bovine calf serum drugs at or above their therapeutic concentrations. The potential for interference was judged by the presence or absence of an interfering peak, the relative retention time of that peak, and peak height with respect to the therapeutic concentrations of the drug. Of the 108 drugs tested, only 16 showed peaks that would overlap within ± 0.1 relative retention time of the peaks for fluoxetine, norfluoxetine, or the internal standard ( The remaining 68 drugs do not extract and provide no interference with fluoxetine quantification at concentrations well above therapeutic (except where noted in Table 2 ).
Method Validation
The automated
Gilson Aspec analysis (y) was compared with a manual HPLC method (14) performed in a regional reference laboratory (x). Of 74 specimens assayed, 16 exhibited additional chromatographic peaks. Although no interference was noted with the automated method, an extensive drug interference study was not availablefor the manual comparison method (14), so the potential for interference could not be estimated. Therefore, these 16 samples were excluded from the correlation study (Fig. 3) 
